The benefits of HU in patients with SCD are attributed to elevated fetal Hb levels, as well as total Hb and mean cell volume of red cells, reduced WBC, platelet, and reticulocyte counts, downregulated adhesion molecules, and increased nitric oxide release. This evidence concerns the gene GSTM1 and Schnyder corneal dystrophy.